APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex Concentrate

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human Prothrombin Complex Concentrate Industry Research Report 2026

22 December 2025133 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Concentrate Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Concentrate Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Concentrate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Concentrate Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Prothrombin Complex Concentrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Human Prothrombin Complex Concentrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Human Prothrombin Complex Concentrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Human Prothrombin Complex Concentrate include Takeda, Weiguang Biology, Thailand Bio, Shanghai Emerging Pharmaceuticals, Shanghai RAAS, Green Cross (China) Biological Products Co., Ltd., Jiangxi Boya Biopharmaceutical Co., Ltd., Hualan Bio and Guangdong Shuanglin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Human Prothrombin Complex Concentrate market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Prothrombin Complex Concentrate Market by Company

Takeda

Weiguang Biology

Thailand Bio

Shanghai Emerging Pharmaceuticals

Shanghai RAAS

Green Cross (China) Biological Products Co., Ltd.

Jiangxi Boya Biopharmaceutical Co., Ltd.

Hualan Bio

Guangdong Shuanglin Biopharmaceutical Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Beijing Bohui Innovative Biotechnology Group Co., Ltd.

Octapharma

Grifols

CSL

Biotest

Human Prothrombin Complex Concentrate Segment by Type

500 IU

1000 IU

Human Prothrombin Complex Concentrate Segment by Application

Hemophilia B

Vitamin K Deficiency

Other

Human Prothrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Prothrombin Complex Concentrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Prothrombin Complex Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Prothrombin Complex Concentrate Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Prothrombin Complex Concentrate Sales (k units) of Manufacturers (2021-2026) Table 7. Global Human Prothrombin Complex Concentrate Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Prothrombin Complex Concentrate Revenue of Manufacturers (2021-2026) Table 9. Global Human Prothrombin Complex Concentrate Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Prothrombin Complex Concentrate Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Human Prothrombin Complex Concentrate Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Prothrombin Complex Concentrate, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Prothrombin Complex Concentrate, Product Type & Application Table 14. Global Human Prothrombin Complex Concentrate Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Prothrombin Complex Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Company Information Table 19. Takeda Business Overview Table 20. Takeda Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Takeda Human Prothrombin Complex Concentrate Product Portfolio Table 22. Takeda Recent Developments Table 23. Weiguang Biology Company Information Table 24. Weiguang Biology Business Overview Table 25. Weiguang Biology Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio Table 27. Weiguang Biology Recent Developments Table 28. Thailand Bio Company Information Table 29. Thailand Bio Business Overview Table 30. Thailand Bio Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio Table 32. Thailand Bio Recent Developments Table 33. Shanghai Emerging Pharmaceuticals Company Information Table 34. Shanghai Emerging Pharmaceuticals Business Overview Table 35. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio Table 37. Shanghai Emerging Pharmaceuticals Recent Developments Table 38. Shanghai RAAS Company Information Table 39. Shanghai RAAS Business Overview Table 40. Shanghai RAAS Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio Table 42. Shanghai RAAS Recent Developments Table 43. Green Cross (China) Biological Products Co., Ltd. Company Information Table 44. Green Cross (China) Biological Products Co., Ltd. Business Overview Table 45. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 47. Green Cross (China) Biological Products Co., Ltd. Recent Developments Table 48. Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information Table 49. Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview Table 50. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 52. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments Table 53. Hualan Bio Company Information Table 54. Hualan Bio Business Overview Table 55. Hualan Bio Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio Table 57. Hualan Bio Recent Developments Table 58. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information Table 59. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview Table 60. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 62. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments Table 63. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 64. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 65. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 67. Beijing Tiantan Biological Products Co., Ltd. Recent Developments Table 68. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information Table 69. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview Table 70. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 72. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments Table 73. Octapharma Company Information Table 74. Octapharma Business Overview Table 75. Octapharma Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Octapharma Human Prothrombin Complex Concentrate Product Portfolio Table 77. Octapharma Recent Developments Table 78. Grifols Company Information Table 79. Grifols Business Overview Table 80. Grifols Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Grifols Human Prothrombin Complex Concentrate Product Portfolio Table 82. Grifols Recent Developments Table 83. CSL Company Information Table 84. CSL Business Overview Table 85. CSL Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CSL Human Prothrombin Complex Concentrate Product Portfolio Table 87. CSL Recent Developments Table 88. Biotest Company Information Table 89. Biotest Business Overview Table 90. Biotest Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Biotest Human Prothrombin Complex Concentrate Product Portfolio Table 92. Biotest Recent Developments Table 93. Global Human Prothrombin Complex Concentrate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 95. Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2021-2026) Table 96. Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032) & (k units) Table 97. Global Human Prothrombin Complex Concentrate Sales Market Share by Region (2027-2032) Table 98. Global Human Prothrombin Complex Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2021-2026) Table 100. Global Human Prothrombin Complex Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Human Prothrombin Complex Concentrate Revenue Market Share by Region (2027-2032) Table 102. North America Human Prothrombin Complex Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 104. North America Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 105. North America Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Human Prothrombin Complex Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Human Prothrombin Complex Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 109. Europe Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 110. Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Human Prothrombin Complex Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Human Prothrombin Complex Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Human Prothrombin Complex Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Human Prothrombin Complex Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 119. South America Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 120. South America Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Human Prothrombin Complex Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Human Prothrombin Complex Concentrate Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Human Prothrombin Complex Concentrate Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Human Prothrombin Complex Concentrate Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 128. Global Human Prothrombin Complex Concentrate Sales by Type (2027-2032) & (k units) Table 129. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2026) Table 130. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2027-2032) Table 131. Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Human Prothrombin Complex Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2026) Table 134. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2027-2032) Table 135. Global Human Prothrombin Complex Concentrate Price by Type (2021-2026) & (US$/unit) Table 136. Global Human Prothrombin Complex Concentrate Price by Type (2027-2032) & (US$/unit) Table 137. Global Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 138. Global Human Prothrombin Complex Concentrate Sales by Application (2027-2032) & (k units) Table 139. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2026) Table 140. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2027-2032) Table 141. Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Human Prothrombin Complex Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2026) Table 144. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2027-2032) Table 145. Global Human Prothrombin Complex Concentrate Price by Application (2021-2026) & (US$/unit) Table 146. Global Human Prothrombin Complex Concentrate Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Human Prothrombin Complex Concentrate Distributors List Table 150. Human Prothrombin Complex Concentrate Customers List Table 151. Human Prothrombin Complex Concentrate Industry Trends Table 152. Human Prothrombin Complex Concentrate Industry Drivers Table 153. Human Prothrombin Complex Concentrate Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Prothrombin Complex Concentrate Product Image Figure 5. Global Human Prothrombin Complex Concentrate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Prothrombin Complex Concentrate Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Prothrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 8. Global Human Prothrombin Complex Concentrate Average Price (US$/unit) & (2021-2032) Figure 9. 500 IU Product Image Figure 10. 1000 IU Product Image Figure 11. Hemophilia B Product Image Figure 12. Vitamin K Deficiency Product Image Figure 13. Other Product Image Figure 14. Global Human Prothrombin Complex Concentrate Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Human Prothrombin Complex Concentrate, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Human Prothrombin Complex Concentrate Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Human Prothrombin Complex Concentrate Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Human Prothrombin Complex Concentrate Sales by Region in 2025 Figure 20. Global Human Prothrombin Complex Concentrate Revenue by Region in 2025 Figure 21. North America Human Prothrombin Complex Concentrate Market Size by Country in 2025 Figure 22. North America Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 23. North America Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2032) Figure 24. United States Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Human Prothrombin Complex Concentrate Market Size by Country in 2025 Figure 28. Europe Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 29. Europe Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2032) Figure 30. Germany Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Human Prothrombin Complex Concentrate Market Size by Country in 2025 Figure 41. Asia Pacific Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2032) Figure 43. China Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Human Prothrombin Complex Concentrate Market Size by Country in 2025 Figure 52. South America Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 53. South America Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2032) Figure 54. Brazil Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country in 2025 Figure 58. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Human Prothrombin Complex Concentrate Revenue Market Share by Country (2021-2032) Figure 60. Egypt Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Human Prothrombin Complex Concentrate Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2032) Figure 66. Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2032) Figure 67. Global Human Prothrombin Complex Concentrate Price (US$/unit) by Type (2021-2032) Figure 68. Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2032) Figure 69. Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2032) Figure 70. Global Human Prothrombin Complex Concentrate Price (US$/unit) by Application (2021-2032) Figure 71. Human Prothrombin Complex Concentrate Value Chain Figure 72. Human Prothrombin Complex Concentrate Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Human Prothrombin Complex Concentrate Industry Opportunities and Challenges

Scope & coverage.

Types
  • 500 IU
  • 1000 IU
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Other
Companies covered
  • Takeda
  • Weiguang Biology
  • Thailand Bio
  • Shanghai Emerging Pharmaceuticals
  • Shanghai RAAS
  • Green Cross (China) Biological Products Co., Ltd.
  • Jiangxi Boya Biopharmaceutical Co., Ltd.
  • Hualan Bio
  • Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  • Octapharma
  • Grifols
  • CSL
  • Biotest

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Prothrombin Complex Concentrate Market Size (2021-2032)
  4. 2.2.2 Global Human Prothrombin Complex Concentrate Sales (2021-2032)
  5. 2.2.3 Global Human Prothrombin Complex Concentrate Market Average Price (2021-2032)
  6. 2.3 Human Prothrombin Complex Concentrate by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 500 IU
  9. 2.3.3 1000 IU
  10. 2.4 Human Prothrombin Complex Concentrate by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hemophilia B
  13. 2.4.3 Vitamin K Deficiency
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Prothrombin Complex Concentrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Prothrombin Complex Concentrate Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Human Prothrombin Complex Concentrate Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Concentrate Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Prothrombin Complex Concentrate Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Prothrombin Complex Concentrate, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Prothrombin Complex Concentrate, Product Type & Application
  8. 3.8 Global Manufacturers of Human Prothrombin Complex Concentrate, Established Date
  9. 3.9 Global Human Prothrombin Complex Concentrate Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda
  2. 4.1.1 Takeda Company Information
  3. 4.1.2 Takeda Business Overview
  4. 4.1.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Human Prothrombin Complex Concentrate Product Portfolio
  6. 4.1.5 Takeda Recent Developments
  7. 4.2 Weiguang Biology
  8. 4.2.1 Weiguang Biology Company Information
  9. 4.2.2 Weiguang Biology Business Overview
  10. 4.2.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio
  12. 4.2.5 Weiguang Biology Recent Developments
  13. 4.3 Thailand Bio
  14. 4.3.1 Thailand Bio Company Information
  15. 4.3.2 Thailand Bio Business Overview
  16. 4.3.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio
  18. 4.3.5 Thailand Bio Recent Developments
  19. 4.4 Shanghai Emerging Pharmaceuticals
  20. 4.4.1 Shanghai Emerging Pharmaceuticals Company Information
  21. 4.4.2 Shanghai Emerging Pharmaceuticals Business Overview
  22. 4.4.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio
  24. 4.4.5 Shanghai Emerging Pharmaceuticals Recent Developments
  25. 4.5 Shanghai RAAS
  26. 4.5.1 Shanghai RAAS Company Information
  27. 4.5.2 Shanghai RAAS Business Overview
  28. 4.5.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio
  30. 4.5.5 Shanghai RAAS Recent Developments
  31. 4.6 Green Cross (China) Biological Products Co., Ltd.
  32. 4.6.1 Green Cross (China) Biological Products Co., Ltd. Company Information
  33. 4.6.2 Green Cross (China) Biological Products Co., Ltd. Business Overview
  34. 4.6.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  36. 4.6.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments
  37. 4.7 Jiangxi Boya Biopharmaceutical Co., Ltd.
  38. 4.7.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  42. 4.7.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Hualan Bio
  44. 4.8.1 Hualan Bio Company Information
  45. 4.8.2 Hualan Bio Business Overview
  46. 4.8.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio
  48. 4.8.5 Hualan Bio Recent Developments
  49. 4.9 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  50. 4.9.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  54. 4.9.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Beijing Tiantan Biological Products Co., Ltd.
  56. 4.10.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  57. 4.10.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  58. 4.10.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  60. 4.10.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  61. 4.11 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  62. 4.11.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
  63. 4.11.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview
  64. 4.11.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  66. 4.11.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments
  67. 4.12 Octapharma
  68. 4.12.1 Octapharma Company Information
  69. 4.12.2 Octapharma Business Overview
  70. 4.12.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Octapharma Human Prothrombin Complex Concentrate Product Portfolio
  72. 4.12.5 Octapharma Recent Developments
  73. 4.13 Grifols
  74. 4.13.1 Grifols Company Information
  75. 4.13.2 Grifols Business Overview
  76. 4.13.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Grifols Human Prothrombin Complex Concentrate Product Portfolio
  78. 4.13.5 Grifols Recent Developments
  79. 4.14 CSL
  80. 4.14.1 CSL Company Information
  81. 4.14.2 CSL Business Overview
  82. 4.14.3 CSL Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 CSL Human Prothrombin Complex Concentrate Product Portfolio
  84. 4.14.5 CSL Recent Developments
  85. 4.15 Biotest
  86. 4.15.1 Biotest Company Information
  87. 4.15.2 Biotest Business Overview
  88. 4.15.3 Biotest Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Biotest Human Prothrombin Complex Concentrate Product Portfolio
  90. 4.15.5 Biotest Recent Developments
5 Global Human Prothrombin Complex Concentrate Market Scenario by Region
  1. 5.1 Global Human Prothrombin Complex Concentrate Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Prothrombin Complex Concentrate Sales by Region: 2021-2032
  3. 5.2.1 Global Human Prothrombin Complex Concentrate Sales by Region: 2021-2026
  4. 5.2.2 Global Human Prothrombin Complex Concentrate Sales by Region: 2027-2032
  5. 5.3 Global Human Prothrombin Complex Concentrate Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Prothrombin Complex Concentrate Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Prothrombin Complex Concentrate Revenue by Region: 2027-2032
  8. 5.4 North America Human Prothrombin Complex Concentrate Market Facts & Figures by Country
  9. 5.4.1 North America Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  11. 5.4.3 North America Human Prothrombin Complex Concentrate Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human Prothrombin Complex Concentrate Market Facts & Figures by Country
  16. 5.5.1 Europe Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  18. 5.5.3 Europe Human Prothrombin Complex Concentrate Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human Prothrombin Complex Concentrate Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human Prothrombin Complex Concentrate Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human Prothrombin Complex Concentrate Market Facts & Figures by Country
  41. 5.7.1 South America Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  43. 5.7.3 South America Human Prothrombin Complex Concentrate Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human Prothrombin Complex Concentrate Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human Prothrombin Complex Concentrate Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human Prothrombin Complex Concentrate Sales by Type (2021-2032)
  2. 6.1.1 Global Human Prothrombin Complex Concentrate Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Human Prothrombin Complex Concentrate Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Prothrombin Complex Concentrate Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Prothrombin Complex Concentrate Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Prothrombin Complex Concentrate Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Prothrombin Complex Concentrate Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Prothrombin Complex Concentrate Sales by Application (2021-2032)
  2. 7.1.1 Global Human Prothrombin Complex Concentrate Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Human Prothrombin Complex Concentrate Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Prothrombin Complex Concentrate Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Prothrombin Complex Concentrate Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Prothrombin Complex Concentrate Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Prothrombin Complex Concentrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Prothrombin Complex Concentrate Value Chain Analysis
  2. 8.1.1 Human Prothrombin Complex Concentrate Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Prothrombin Complex Concentrate Production Mode & Process
  5. 8.2 Human Prothrombin Complex Concentrate Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Prothrombin Complex Concentrate Distributors
  8. 8.2.3 Human Prothrombin Complex Concentrate Customers
9 Global Human Prothrombin Complex Concentrate Analyzing Market Dynamics
  1. 9.1 Human Prothrombin Complex Concentrate Industry Trends
  2. 9.2 Human Prothrombin Complex Concentrate Industry Drivers
  3. 9.3 Human Prothrombin Complex Concentrate Industry Opportunities and Challenges
  4. 9.4 Human Prothrombin Complex Concentrate Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst